Plain-English translation of NCT07685717 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help elderly patients with a blood cancer called chronic lymphocytic leukemia. is taken as a daily pill, and researchers want to understand how well this treatment works, how many patients can tolerate it, and whether it improves quality of life in older adults with this condition.
Elderly patients with this type of blood cancer often have limited treatment options that are tolerated well. This trial exists to see if the medication offers a gentler but effective choice for older patients who have never received cancer treatment before.
You likely qualify if…
You likely don't qualify if…
You would take the medication by mouth once daily for 28-day cycles, repeating the cycles for as long as the treatment is working and you tolerate it well. Throughout the study, you'll have regular blood tests, CT scans, and possibly bone marrow biopsies to monitor how the medication is working. After you finish treatment, you'll have follow-up visits and then regular check-ins for up to 8 years to track your long-term health.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States